Skip to content

Heba Fathy Mohammed Ismai Maraei, MBCHB

NPI 1316684491ActiveIndividual· Internal Medicine, Nephrology· Seattle, WA

Internal Medicine, Nephrology (MBCHB) in Seattle, Washington, licensed in WA, with an NPI issued in May 2022. Part D covered 107 prescriptions written in 2024, 82% of them generic. Melinta Therapeutics, LLC was the largest of 2 companies reporting payments in 2025, $42.38 in all, mostly food and beverage.

Overview

NPI1316684491
StatusActive
Entity typeIndividual
CredentialMBCHB
Sole proprietorNo
NPI issuedMay 19, 2022
Last updated in NPPESJun 25, 2025
Certified by providerJun 25, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Nephrology (WA)

Part D prescriptions in 2024

Prescriptions (claims)107 · 108 30-day fills
Patients46
Total drug cost$13,382
Generic share82% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$42.38 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Melinta Therapeutics, LLC$22.651
Janssen Biotech, Inc.$19.731

What the 2025 payments were for

  • Food and Beverage$42.38 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nephrologists in Seattle

All 109 nephrologists in Seattle · All nephrologists in Washington